330 related articles for article (PubMed ID: 12761728)
1. Side effects of therapy for chronic hepatitis C.
Russo MW; Fried MW
Gastroenterology; 2003 May; 124(6):1711-9. PubMed ID: 12761728
[No Abstract] [Full Text] [Related]
2. [Adverse reactions of different treatments in chronic hepatitis C].
Luca C; Grigore L; Vâţă A; Dorobăţ C
Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):991-5. PubMed ID: 20191864
[TBL] [Abstract][Full Text] [Related]
3. [Pegylated intereferon hematological safety in comparison with standard].
Fazylov VKh; Manapova ÉR; Tkacheva SV; Sozinova IuM
Eksp Klin Gastroenterol; 2012; (6):96-9. PubMed ID: 23402198
[TBL] [Abstract][Full Text] [Related]
4. Summaries for patients. Duration and dose of antiviral treatment for chronic hepatitis C.
Ann Intern Med; 2004 Mar; 140(5):I67. PubMed ID: 14996694
[No Abstract] [Full Text] [Related]
5. [Side effects of interferon-based therapy for chronic hepatitis C virus infection and clinical management of them].
Iwasaki Y; Ikeda F; Yamamoto K
Nihon Rinsho; 2011 May; 69 Suppl 4():215-20. PubMed ID: 22096922
[No Abstract] [Full Text] [Related]
6. Unilateral hearing loss due to pegylated interferon-α2b and ribavirin therapy.
Jain S; Midha V; Sood A
Indian J Gastroenterol; 2011 Sep; 30(5):239-40. PubMed ID: 21986854
[No Abstract] [Full Text] [Related]
7. Autoimmune thrombocytopenia induced by PEG-IFN-alpha2b plus ribavirin in hepatitis C.
Sagir A; Wettstein M; Heintges T; Häussinger D
Dig Dis Sci; 2002 Mar; 47(3):562-3. PubMed ID: 11911342
[No Abstract] [Full Text] [Related]
8. Hematologic side effects of PEG interferon and ribavirin. Management with growth factors.
Keeffe EB; Kowdley KV
J Clin Gastroenterol; 2005 Jan; 39(1 Suppl):S1-2. PubMed ID: 15597022
[No Abstract] [Full Text] [Related]
9. Thyroid function and changes in ultrasound morphology during antiviral therapy with pegylated interferon and ribavirin in patients with chronic hepatitis C.
Friedrich-Rust M; Theobald J; Zeuzem S; Bojunga J
J Viral Hepat; 2009 Mar; 16(3):168-77. PubMed ID: 19175874
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the adverse effect of premature discontinuation of pegylated interferon α-2b and ribavirin treatment for chronic hepatitis C virus infection: results from Kyushu University Liver Disease Study.
Ogawa E; Furusyo N; Kajiwara E; Takahashi K; Nomura H; Tanabe Y; Satoh T; Maruyama T; Nakamuta M; Kotoh K; Azuma K; Dohmen K; Shimoda S; Hayashi J;
J Gastroenterol Hepatol; 2012 Jul; 27(7):1233-40. PubMed ID: 22098185
[TBL] [Abstract][Full Text] [Related]
11. Interferon-induced thyroid dysfunction--not always transient.
Wong VW; Cheng AY; Chan HL
J Gastroenterol Hepatol; 2009 Jun; 24(6):938-40. PubMed ID: 19638076
[No Abstract] [Full Text] [Related]
12. Managing adverse effects of interferon-alfa and ribavirin in combination therapy for HCV.
Slim J; Afridi MS
Infect Dis Clin North Am; 2012 Dec; 26(4):917-29. PubMed ID: 23083824
[TBL] [Abstract][Full Text] [Related]
13. Alopecia universalis as a side effect of pegylated interferon α-ribavirin combination therapy for hepatitis C: a rare case report.
Verma P; Dayal S; Jain VK; Amrani A
J Chemother; 2017 Dec; 29(6):380-382. PubMed ID: 27741937
[TBL] [Abstract][Full Text] [Related]
14. Severe autoimmune hemolytic anemia in a patient with chronic hepatitis C during treatment with Peg interferon alfa-2a and ribavirin.
Ennaifer R; Cheikh M; Romdhane H; Hefaiedh R; Ben Nejma H; Bel Hadj N
Tunis Med; 2014 Jan; 92(1):42-3. PubMed ID: 24879173
[No Abstract] [Full Text] [Related]
15. [Thyroid dysfunctions in children with chronic hepatitis C during interferon alpha-2b therapy].
Kupś-Rzepecka J; Woźniakowska-Gesicka T; Gołabek V
Przegl Lek; 2011; 68(6):311-5. PubMed ID: 22039668
[TBL] [Abstract][Full Text] [Related]
16. [Diabetes mellitus during interferon therapy].
Tarabini-Castellani P; Apraiz L; Portu J; Agud JM
Enferm Infecc Microbiol Clin; 2008 Feb; 26(2):120-1. PubMed ID: 18341927
[No Abstract] [Full Text] [Related]
17. Retinal vein thrombosis associated with peginterferon alpha 2b plus ribavirin in a chronic hepatitis C patient.
Such Díaz A; Barrueco N; Esteban Alba C; Escobar Rodríguez I
Farm Hosp; 2011; 35(2):93-4. PubMed ID: 20615736
[No Abstract] [Full Text] [Related]
18. Mania during treatment of chronic hepatitis C with pegylated interferon and ribavirin.
Onyike CU; Bonner JO; Lyketsos CG; Treisman GJ
Am J Psychiatry; 2004 Mar; 161(3):429-35. PubMed ID: 14992966
[No Abstract] [Full Text] [Related]
19. [Pegylated interferon alfa-2a. Improved prognosis in hepatitis C].
MMW Fortschr Med; 2002 Sep; 144(38):59. PubMed ID: 12395712
[No Abstract] [Full Text] [Related]
20. [Hepatitis C infection. Overweight virus carriers are more difficult to cure].
MMW Fortschr Med; 2004 Mar; 146(13):58. PubMed ID: 15219135
[No Abstract] [Full Text] [Related]
[Next] [New Search]